Edwards Lifesciences Corp (EW)

$75.32 +1.49 (2.02%)
Market Cap 43.31B
Revenue (ttm) 5.44B
Net Income (ttm) 4.17B
EPS (ttm) N/A
PE Ratio 28.40
Forward PE 30.02
Profit Margin 76.75%
Debt to Equity Ratio 0.06
Volume 3,749,997
Avg Vol 4,500,572
Day's Range N/A - N/A
Shares Out 586.60M
Stochastic %K 28%
Beta 1.12
Analysts Sell
Price Target $80.67

Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. I...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 250 2500
Address:
One Edwards Way, Irvine, United States
OptionRunners
OptionRunners Jun. 18 at 3:28 PM
$EW Buyer of the July 18th $75 calls 2,000 times for $1.55-$1.60
0 · Reply
TradeInYourJob
TradeInYourJob Jun. 16 at 1:10 PM
$EW Sell signal on the weekly timeframe CCI, onbalance volume with a negative divergence, under the declining 200 MA.
0 · Reply
gargoyl
gargoyl Jun. 10 at 3:49 PM
$BLRX 👀 If a whale 🐳 eats the spoof at 6.49 we Fly 🦅 $PFE $EW
0 · Reply
kcphaeton
kcphaeton Jun. 5 at 3:15 AM
$BSX $EW what do you see being key drivers to get our PPS up in Edwards?
0 · Reply
StocktwitsNews
StocktwitsNews May. 28 at 4:50 PM
Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightens $BSX $EW $MDT https://stocktwits.com/news/equity/markets/boston-scientific-discontinues-worldwide-sales-of-acurate-aortic-valve-systems/ch0oF7wRbsN
0 · Reply
OptionRunners
OptionRunners May. 28 at 2:15 PM
$EW Buyer of the July 18th $77.50 calls 2,000 times for $3.50
0 · Reply
OpenOutcrier
OpenOutcrier May. 28 at 12:30 PM
$EW (+2.3% pre) Edwards Lifesciences (EW) gains after Boston Scientific $BSX ends worldwide sales of the ACURATE neo2 and ACURATE Prime https://ooc.bz/l/66054
0 · Reply
DonCorleone77
DonCorleone77 May. 28 at 12:22 PM
$BSX $EW Boston Scientific discontinuing worldwide sales of ACURATE Aortic Valve Systems In a regulatory filing, Boston Scientific (BSX) disclosed that it announced it is discontinuing worldwide sales of the ACURATE neo2 and ACURATE Prime Aortic Valve Systems and no longer pursuing U.S. FDA approval for ACURATE or approval in other geographies. "The company made this decision based on recent discussions with regulators, which resulted in increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions. The additional resources and investments needed to satisfy these requirements are prohibitive for the company. Based on the information known today and despite the anticipated financial impacts from the discontinuation of ACURATE, the company expects to achieve its second quarter and full year 2025 reported and organic sales and adjusted earnings per share guidance issued on April 23, 2025. The company is not reaffirming its second quarter and full year 2025 GAAP EPS guidance issued on April 23, 2025 at this time and expects to provide more information during the company's second quarter 2025 earnings call," Boston Scientific stated in the filing.
0 · Reply
JarvisFlow
JarvisFlow May. 22 at 5:28 PM
Citigroup has updated their rating for Edwards Lifesciences ( $EW ) to Buy with a price target of 95.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 22 at 9:44 AM
WATCHLIST MAY 22 2025 $SLAB Silicon Labs Unveils SiXG301 And SiXG302 SoCs To Power High-Performance, Energy-Efficient IoT Applications $AMZN Baidu's Apollo Go Enters Dubai And Abu Dhabi, CEO Robin Li Touts Global Robotaxi Lead With 1.4 Million Rides In Q1 $HON Honeywell To Acquire Johnson Matthey's Catalyst Technologies For £1.8B, Expanding Energy And Sustainability Portfolio $EW Edwards Lifesciences Announced New Economic And Clinical Evidence On Severe Aortic Stenosis Presented As A Late-breaking Clinical Trial At EuroPcr 2025, Further Contributing To The Extensive Body Of Research On This Disease $BIDU Gary Black Calls Tesla Rival Baidu's Apollo Go 'Autonomous Ride Hailing Leader' Following Eleven Million Paid Robotaxi Rides Milestone
0 · Reply
Latest News on EW
Edwards Lifesciences: With A Heart Beating Strong And Steady

Jun 4, 2025, 2:11 PM EDT - 19 days ago

Edwards Lifesciences: With A Heart Beating Strong And Steady

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

May 22, 2025, 2:30 AM EDT - 4 weeks ago

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

Trade Tracker: Bill Baruch buys Edwards Lifesciences

May 19, 2025, 2:13 PM EDT - 5 weeks ago

Trade Tracker: Bill Baruch buys Edwards Lifesciences

Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

May 6, 2025, 7:05 AM EDT - 6 weeks ago

Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

May 1, 2025, 8:00 AM EDT - 7 weeks ago

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

Apr 24, 2025, 2:42 PM EDT - 2 months ago

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript

Apr 23, 2025, 9:35 PM EDT - 2 months ago

Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript

Edwards Lifesciences raises 2025 sales forecast after robust quarter

Apr 23, 2025, 5:43 PM EDT - 2 months ago

Edwards Lifesciences raises 2025 sales forecast after robust quarter

Edwards Lifesciences Reports First Quarter Results

Apr 23, 2025, 4:15 PM EDT - 2 months ago

Edwards Lifesciences Reports First Quarter Results

Eight-Year Data Confirm Long-Term Durability of Edwards' RESILIA Tissue

Apr 18, 2025, 8:00 AM EDT - 2 months ago

Eight-Year Data Confirm Long-Term Durability of Edwards' RESILIA Tissue

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025

Apr 16, 2025, 7:05 AM EDT - 2 months ago

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025

Edwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral Valve Replacement System

Apr 14, 2025, 8:00 AM EDT - 2 months ago

Edwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral Valve Replacement System

New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients

Mar 31, 2025, 2:00 PM EDT - 3 months ago

New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead

Mar 22, 2025, 11:51 PM EDT - 3 months ago

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead

Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor

Mar 6, 2025, 8:00 AM EST - 3 months ago

Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

Feb 25, 2025, 7:05 AM EST - 4 months ago

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

Feb 12, 2025, 2:51 PM EST - 4 months ago

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

Edwards Lifesciences Corporation (EW) Q4 2024 Earnings Call Transcript

Feb 11, 2025, 9:46 PM EST - 4 months ago

Edwards Lifesciences Corporation (EW) Q4 2024 Earnings Call Transcript

Edwards Lifesciences beats profit estimate on strength in heart devices

Feb 11, 2025, 4:19 PM EST - 4 months ago

Edwards Lifesciences beats profit estimate on strength in heart devices

Edwards Lifesciences Reports Fourth Quarter Results

Feb 11, 2025, 4:15 PM EST - 4 months ago

Edwards Lifesciences Reports Fourth Quarter Results

Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025

Feb 4, 2025, 7:05 AM EST - 4 months ago

Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

Jan 30, 2025, 2:21 PM EST - 5 months ago

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

Wedgewood Partners: Q4 And 2024 Top Performers And Detractors

Jan 16, 2025, 8:00 AM EST - 5 months ago

Wedgewood Partners: Q4 And 2024 Top Performers And Detractors

BKNG CDW GOOG GOOGL META MSI ODFL

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 7:05 AM EST - 5 months ago

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

4 Strong Stock Charts For 2025 (Technical Analysis)

Dec 30, 2024, 12:00 PM EST - 6 months ago

4 Strong Stock Charts For 2025 (Technical Analysis)

DRI JBL KR

EW FINAL DEADLINE FRIDAY: Edwards Lifesciences Investors have Until Tomorrow December 13 before Expiration of Court Deadline - Contact BFA Law

Dec 12, 2024, 3:18 PM EST - 6 months ago

EW FINAL DEADLINE FRIDAY: Edwards Lifesciences Investors have Until Tomorrow December 13 before Expiration of Court Deadline - Contact BFA Law

DEADLINE TOMORROW: Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out

Dec 12, 2024, 8:45 AM EST - 6 months ago

DEADLINE TOMORROW: Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out

Investors With Losses Are Invited To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation

Dec 11, 2024, 5:45 PM EST - 6 months ago

Investors With Losses Are Invited To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation

EW SECURITIES FRAUD: Edwards Lifesciences Investors are Notified that the Company was Sued for Securities Fraud – Contact BFA Law by December 13 Deadline if You Lost Money

Dec 11, 2024, 3:42 PM EST - 6 months ago

EW SECURITIES FRAUD: Edwards Lifesciences Investors are Notified that the Company was Sued for Securities Fraud – Contact BFA Law by December 13 Deadline if You Lost Money

EW Deadline: Rosen Law Firm Urges Edwards Lifesciences Corporation (NYSE: EW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Dec 11, 2024, 1:55 PM EST - 6 months ago

EW Deadline: Rosen Law Firm Urges Edwards Lifesciences Corporation (NYSE: EW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out

Dec 10, 2024, 6:15 PM EST - 6 months ago

Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out

Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Encourages Affected Stockholders To Reach Out

Dec 8, 2024, 5:30 PM EST - 7 months ago

Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Encourages Affected Stockholders To Reach Out

Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Invites Shareholder Contributions

Dec 6, 2024, 10:00 AM EST - 7 months ago

Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Invites Shareholder Contributions

Investors With Losses Are Encouraged To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation

Dec 5, 2024, 10:45 AM EST - 7 months ago

Investors With Losses Are Encouraged To Join The Schall Law Firm In A Fraud Case Against Edwards Lifesciences Corporation

Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Invites Stockholder Contributions

Dec 4, 2024, 6:15 PM EST - 7 months ago

Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Invites Stockholder Contributions

OptionRunners
OptionRunners Jun. 18 at 3:28 PM
$EW Buyer of the July 18th $75 calls 2,000 times for $1.55-$1.60
0 · Reply
TradeInYourJob
TradeInYourJob Jun. 16 at 1:10 PM
$EW Sell signal on the weekly timeframe CCI, onbalance volume with a negative divergence, under the declining 200 MA.
0 · Reply
gargoyl
gargoyl Jun. 10 at 3:49 PM
$BLRX 👀 If a whale 🐳 eats the spoof at 6.49 we Fly 🦅 $PFE $EW
0 · Reply
kcphaeton
kcphaeton Jun. 5 at 3:15 AM
$BSX $EW what do you see being key drivers to get our PPS up in Edwards?
0 · Reply
StocktwitsNews
StocktwitsNews May. 28 at 4:50 PM
Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightens $BSX $EW $MDT https://stocktwits.com/news/equity/markets/boston-scientific-discontinues-worldwide-sales-of-acurate-aortic-valve-systems/ch0oF7wRbsN
0 · Reply
OptionRunners
OptionRunners May. 28 at 2:15 PM
$EW Buyer of the July 18th $77.50 calls 2,000 times for $3.50
0 · Reply
OpenOutcrier
OpenOutcrier May. 28 at 12:30 PM
$EW (+2.3% pre) Edwards Lifesciences (EW) gains after Boston Scientific $BSX ends worldwide sales of the ACURATE neo2 and ACURATE Prime https://ooc.bz/l/66054
0 · Reply
DonCorleone77
DonCorleone77 May. 28 at 12:22 PM
$BSX $EW Boston Scientific discontinuing worldwide sales of ACURATE Aortic Valve Systems In a regulatory filing, Boston Scientific (BSX) disclosed that it announced it is discontinuing worldwide sales of the ACURATE neo2 and ACURATE Prime Aortic Valve Systems and no longer pursuing U.S. FDA approval for ACURATE or approval in other geographies. "The company made this decision based on recent discussions with regulators, which resulted in increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions. The additional resources and investments needed to satisfy these requirements are prohibitive for the company. Based on the information known today and despite the anticipated financial impacts from the discontinuation of ACURATE, the company expects to achieve its second quarter and full year 2025 reported and organic sales and adjusted earnings per share guidance issued on April 23, 2025. The company is not reaffirming its second quarter and full year 2025 GAAP EPS guidance issued on April 23, 2025 at this time and expects to provide more information during the company's second quarter 2025 earnings call," Boston Scientific stated in the filing.
0 · Reply
JarvisFlow
JarvisFlow May. 22 at 5:28 PM
Citigroup has updated their rating for Edwards Lifesciences ( $EW ) to Buy with a price target of 95.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 22 at 9:44 AM
WATCHLIST MAY 22 2025 $SLAB Silicon Labs Unveils SiXG301 And SiXG302 SoCs To Power High-Performance, Energy-Efficient IoT Applications $AMZN Baidu's Apollo Go Enters Dubai And Abu Dhabi, CEO Robin Li Touts Global Robotaxi Lead With 1.4 Million Rides In Q1 $HON Honeywell To Acquire Johnson Matthey's Catalyst Technologies For £1.8B, Expanding Energy And Sustainability Portfolio $EW Edwards Lifesciences Announced New Economic And Clinical Evidence On Severe Aortic Stenosis Presented As A Late-breaking Clinical Trial At EuroPcr 2025, Further Contributing To The Extensive Body Of Research On This Disease $BIDU Gary Black Calls Tesla Rival Baidu's Apollo Go 'Autonomous Ride Hailing Leader' Following Eleven Million Paid Robotaxi Rides Milestone
0 · Reply
11thestate
11thestate May. 21 at 11:19 AM
$EW stockholders filed a claim against Edwards Lifesciences for allegedly overstating the growth potential of its TAVR platform and not disclosing competitive challenges that affected demand. You can join this case to be notified about any new information: https://11th.com/cases/edwards-lifesciences-investor-suit
0 · Reply
TradeMyChart
TradeMyChart May. 20 at 5:15 AM
$EW OPTX volume pivots marked
0 · Reply
GettnFibbywIT
GettnFibbywIT May. 18 at 6:31 AM
$EW $XLV $IHI $SPY Might be time for EW to get going again around the current potential level of "polarity" here with some recent momentum that's been coming in (After being rejected around the "1/2 gap" area multiple times) and eventually fill its 7/25/24 gap over time:
0 · Reply
TheOptionsOracleUSA
TheOptionsOracleUSA May. 16 at 6:57 PM
📉 Take Profit Alert 🧠 Closed out two high-probability credit spreads on $EW and $ABBV for solid gains — both trades played out well. 🟢 $EW Bull Put Spread: 69% of max profit 🔴 $ABBV Bear Call Spread: 54% of max profit
0 · Reply
ZacksResearch
ZacksResearch May. 16 at 10:37 AM
$EW stock is on investors' radar due to the promising structural heart opportunities and impressive TMTT portfolio. Explore further: https://www.zacks.com/stock/news/2472713/should-edwards-lifesciences-stock-remain-in-your-portfolio-now?cid=sm-stocktwits-2-2472713-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2472713_TEASER
0 · Reply
kcphaeton
kcphaeton May. 15 at 3:34 AM
$EW prior to the Covid shut down Edwards was doing great. They could do no wrong. I wish they could get their mojo back.
0 · Reply
kcphaeton
kcphaeton May. 13 at 12:27 AM
$EW have held Edwards since 2012. I wish it would get out of this anemic trading range.
1 · Reply
11thestate
11thestate May. 12 at 11:31 AM
$EW stockholders filed a claim against Edwards Lifesciences for misleading them about the growth prospects of its TAVR platform. You can check if you are eligible and file for the payment here: https://11th.com/cases/edwards-lifesciences-investor-suit
0 · Reply
Villidj_Idjit
Villidj_Idjit May. 11 at 9:38 AM
$EW seems to peak in July. #seasonality
0 · Reply
Buy_Last_Dip
Buy_Last_Dip May. 10 at 12:54 AM
$EW dammit. I was so close to sell it. 40c away. Now gotta wait for months
0 · Reply
11thestate
11thestate May. 5 at 10:39 AM
$EW stockholders filed a claim against Edwards Lifesciences for misleading them about the growth prospects of its TAVR platform. You can check if you are eligible and file for the payment here: https://11th.com/cases/edwards-lifesciences-investor-suit
0 · Reply
EPSMomentumStocks
EPSMomentumStocks Apr. 30 at 11:33 AM
A modeled prediction of $EW’s potential price movement range following its earnings report, visualized through a drift cone that captures the expected volatility and directional bias influenced by historical post-earnings performance trends. #stocks #trading #investing
0 · Reply